GLP-1 & metabolic health · November 2026
GLP-1 Medicines: Weight & Health
GLP-1 medicines, sleep, and the life beyond a prescription
Read the magazine Download PDFTHE ARISING / Everyday health
GLP-1 & metabolic health
Beyond the First Prescription
A monthly magazine series
All editions
Connected reading
- Remission is a beginning. What helps it last?
- Retatrutide: greater weight loss, more treatment withdrawals
- GLP-1 medicines and bone density: what eight trials can tell us
- The liver test that could spare a biopsy—but only for the question it answers well
- The glucose sensor crossed a boundary: benefit without insulin therapy
- Coaching Program Linked to Greater Weight Loss in GLP-1 Users
- Lilly's Triple-Hormone Drug Retatrutide Beat Ozempic on Blood Sugar and Weight at Its Top Dose
- Normal body weight does not guarantee protection from fatty liver disease
- GLP-1 cardiovascular protection appears similar across age groups
- Weight and Blood Sugar Rose Fastest in the First 90 Days After Starting Antipsychotics, Study Finds
- Whole-Body MRI Study of 14,031 Adults Links Sleep to Belly Fat
- Bone Density Fell in GLP-1 Trials With the Most Weight Loss